GIANG TRAN: Open Payments
NPI 1649915422 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 13 payments from 8 companies in 2025. Trend: 2023 $229 · 2024 $295 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $137 |
| Novartis Pharmaceuticals Corporation | 5 | $136 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| Boston Scientific Corporation | 1 | $30 |
| Novo Nordisk Inc | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
| Amgen Inc. | 1 | $15 |
Products named: SYMPLICITY G3, LEQVIO, CAMZYOS, BodyGuardian, Ozempic, INSPIRE, LifeVest, ELIQUIS.
Industry payments across TX — which companies pay providers there.
